| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-09 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-09 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |